NEXIMMUNE, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.46 USD | +10.90% |
|
+2.67% | +55.86% |
| 17/04 | North American Morning Briefing : Stock Futures -2- | DJ |
| 16/04 | NexImmune, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar NexImmune, Inc.
d1ed0bf58af1bc452b5096cf0.WLugGmcQd3wSljUxpydHa1GY_XVCJ7Tk0yZrNR8u5HM.L_aTLDZbExlYoHx96nJ2PCTQqiAzaty-nVEhQy5K0hgx4vdLE3YQK1zZVg~b8c2e93b68d3f5a302bfc0b91095ad0a
Upcoming events on NexImmune, Inc.
Past events on NexImmune, Inc.
| 07/02/2024 08:30 pm | Extraordinary Shareholders Meeting - Restructuring Vote |
| 21/12/2023 08:30 pm | Extraordinary Shareholders Meeting |
| 04/11/2023 09:30 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number: 396 |
| 03/11/2023 09:30 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number: 395 |
| 03/11/2023 09:30 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number: 1139 |
| 17/10/2023 07:30 pm | Extraordinary Shareholders Meeting |
| 12/09/2023 | H.C. Wainwright Global Investment Conference |
| 11/08/2023 01:31 am | Q2 2023 Earnings Release |
| 20/06/2023 | Federation of Clinical Immunology Societies Meeting - Abstract #: 1515606 |
| 02/06/2023 | American Society of Clinical Oncology Conference - Abstract No : 7043 |
| 17/05/2023 | Annual General Meeting |
| 16/05/2023 01:31 am | Q1 2023 Earnings Release |
| 29/03/2023 01:31 am | Q4 2022 Earnings Release |
| 15/11/2022 02:31 am | Q3 2022 Earnings Release |
| 12/09/2022 08:30 pm | H.C. Wainwright Global Investment Conference |
| 16/08/2022 01:35 am | Interim 2022 Earnings Release |
| 13/06/2022 07:30 pm | Annual General Meeting |
| 13/05/2022 01:31 am | Q1 2022 Earnings Release |
| 17/03/2022 06:00 pm | Barclays Global Healthcare Conference |
| 10/03/2022 03:03 am | FY 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -27,9 -27,5 -1.28% | -53,3 -57,1 6.79% | -63,1 -59,9 -5.23% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -50,9 -54,5 6.54% | -62,5 -59,6 -4.87% |
|
Net income Million USD | Released Forecast Spread | -23,2 | 0,00 0,00 - | -50,9 -54,8 7.18% | -62,5 -59,6 -4.87% |
|
EPS USD | Released Forecast Spread | -27,0 | 0,00 0,00 - | -63,5 -65,9 3.61% | -65,0 -61,5 -5.69% |
| Announcement Date | 14/12/20 | 31/03/21 | 09/03/22 | 28/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -15,5 -19,4 20.03% | -15,1 -16,5 8.72% | -15,9 -15,3 -4.19% | -14,9 -16,1 8% | -17,2 -14,1 -22.21% | -9,83 -12,1 18.62% | -7,78 -7,86 0.96% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,5 -19,1 18.65% | -15,0 -16,1 6.88% | -15,9 -15,3 -3.95% | -14,7 -16,1 8.59% | -16,9 -14,1 -20.18% | -9,57 -11,8 18.73% | -7,57 -7,67 1.29% |
|
Net income Million USD | Released Forecast Spread | -15,5 -19,1 18.65% | -15,0 -16,1 6.88% | -15,9 -15,3 -3.95% | -14,7 -16,1 8.59% | -16,9 -14,1 -20.18% | -9,57 -11,8 18.73% | -7,57 -7,67 1.29% |
|
EPS USD | Released Forecast Spread | -17,3 -19,1 9.8% | -16,5 -17,8 7.04% | -17,3 -17,0 -1.47% | -15,0 -17,4 13.67% | -16,3 -12,9 -26.21% | -9,25 -11,6 20.43% | -7,25 -7,25 0% |
| Announcement Date | 09/03/22 | 12/05/22 | 15/08/22 | 14/11/22 | 28/03/23 | 15/05/23 | 10/08/23 |
More events
Past sector events for NexImmune, Inc.
| 03/05/2024 01:35 am | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:32 am | ARDELYX, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 03/05/2024 01:30 am | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 08:30 pm | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BICYCLE THERAPEUTICS PLC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NEXI Stock
- Calendar NexImmune, Inc.
